Searched for
GLIVEC PATENT CASE
Why SC ruling won't bring down drug pricesDespite the SC verdict, Indian generics makers won't be falling over each other to take on Big Pharma and launch cheaper versions of their ...- Glivec lesson for pharma: Patented drugs must be priced smartlyGlivec was the first-of-its-kind cancer drug for leukaemia patients with patent protection in nearly 40 countries.
- Glivec patent: All eyes on SC today; ruling to decide what can be patented in IndiaOn Monday, the Supreme Court is scheduled to pronounce its verdict on a case that will have profound implications on what can or cannot be ...
- Novartis fears it may lose Glivec case in Supreme CourtThe Supreme Court is slated to announce a verdict in the case filed by Novartis in 2006 against the Indian government, challenging a key pu...
- Novartis India keeps fingers crossed as SC hears glivec patent caseThe Indian subsidiary of Swiss drug maker Novartis is making a final attempt at getting a patent for its anti-cancer drug Imatinib with the...
- Novartis moves SC in Glivec patent caseSwiss major Novartis AG has moved the Supreme Court challenging Intellectual Property Appellate Board (IPAB) decision to reject its patent ...
- HC breather for Novartis in Glivec patent appealThe Madras High Court has cleared a government proposal to exclude a technical member of the Intellectual Property Appellate Board (IPAB) f...
- Govt moves new proposal before HC on Glivec caseThe government has submitted a new proposal with the Madras High Court to let the chairman and vice-chairman of the Intellectual Property A...
- HC to hear Novartis case on October 8The Madras High Court will hear on October 8, Novartis' objection to the appointment of S Chandrasekaran, former Controller General of the ...
- HC suspends hearings in Novartis' Glivec caseHearings in Novartis’ appeal against the rejection of patent for its anti-cancer drug Glivec have been suspended yet again, after the Madra...
- Glivec patent appeal's pendingNovartis has lost its challenge against the Indian government on the question of patent for incremental innovation, but its specific appeal...
- It's D-day for Novartis' Glivec caseThis case may have a profound impact on patients’ access to generic medicines in India.
- Novartis not to plead Glivec caseNovartis moves to Madras HC seeking removal of former patent chief from IPAB.
- Setback for Novartis as Chandrasekaran staysThe Indian Patent Appellate Board dismisses Novartis' objection to the appointment of S Chandrasekaran.
- IPAB hears Novartis’ objection against S ChandrasekaranThe Indian Patent Appellate Board (IPAB) on Monday heard a case that will decide whether S Chandrasekaran, former controller general of pat...
- Novartis hits a blind spot with Glivec appealIn a new twist to the globally-publicised Glivec case, Novartis has objected to the appointment of the former controller general of patents...
- Madras HC to rule on Novartis’ patent caseWhen Novartis AG was accused of jeopardising patients’ access to generic medicines in India last year, the Swiss drug giant thought it woul...
- Wait gets longer for HC ruling in Glivec caseThe wait could be longer than expected for the Madras High Court ruling on the controversial Glivec case.
- Novartis challenges Patents Act provisionFollowing the rejection of its patent application for anti-cancer drug Glivec, Swiss pharmaceutical giant Novartis is not only challenging ...
- Novartis takes on patent law in Glivec caseFollowing rejection of its patent application for anti-cancer drug Glivec, Swiss pharmaceutical giant Novartis AG is not only challenging t...
Load More
